Browse Data and Analysis

Colombia’s agricultural industry widely utilizes innovative biotechnologies, and its regulatory environment remains open genetically engineered (GE) derived commodities. However, congressional anti-biotechnology initiatives continue to risk undoing decades of scientific advancement, undermining biotechnology development and potentially impacting agricultural trade.

While Colombia´s regulatory environment remains friendly toward the adoption of biotechnology-derived crops and products, congressional anti-biotechnology initiatives pose a threat to further acceptance, and risk undermining future investments to benefit consumers and the agricultural sector.

While Colombia's regulatory environment remains friendly toward the adoption of biotech-derived commodities and other innovative technologies, Congressional anti-biotechnology initiatives continue posing a threat, risking the benefits to consumers and the agricultural sector. In 2021, genetically engineered corn area planted grew 31 percent, reaching record figures, and genetically engineered cotton area planted recovered 55 percent compared to 2020.

With international funding to develop and implement biosafety regulatory systems drying up in 2019, Caribbean biosafety regulatory efforts remain in idle mode. The region is seeking further funding from the United Nations Environmental Program/Global...

Colombia remains open to biotechnology and other innovative technologies. In 2020, Colombia's GE corn acreage grew 23 percent while GE cotton acreage declined 37 percent.

Colombia remains open to the adoption of biotech-derived commodities and innovative technologies.

On April 22, 2020, the Food and Surveillance Institute, INVIMA, issued communication IVC-INS-LI15 which establishes the frequency that importers must present laboratory results...

Colombia remains open to the adoption of biotech-derived commodities and innovative technologies.

Many Caribbean Community (CARICOM) Member States have undertaken efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

Colombia remains open to the adoption of biotech-derived commodities and innovative technologies.

Many Caribbean Community (CARICOM) Member States have engaged in efforts to comply with their obligations under the Cartagena Protocol on Biosafety (CPB) to the Convention on Biological Diversity....

Colombia remains open to the adoption of biotech-derived commodities. Area planted of GE (genetically engineered) corn reached its highest adoption rate this past year.